Institutional Giants Step Into POET Technologies as Production Ramp-Up Nears and Legal Overhang Lingers
Veröffentlicht: 15.07.2026 um 20:23 Uhr, Redaktion boerse-global.deTwo of Wall Street’s most formidable hedge funds have taken significant stakes in POET Technologies at a moment when the optical semiconductor specialist is simultaneously battling a class-action lawsuit and gearing up to scale its 800G optical engines. Citadel disclosed a passive holding of between 5.1% and 5.9% on July 8, while Jane Street revealed a 6.8% position. Their entries come during a period of extreme turbulence: the stock has lost roughly 34% over the past month and sits 58% below its 52-week high of €18.84, reached last May.
The share price has shown signs of a tentative rebound. On Wednesday, POET climbed 3.81% to €7.90 on the Frankfurt exchange, adding to a weekly gain of 6.18%. Yet the longer-term trend remains deeply negative. The annualized 30-day volatility is running at 114%, a figure more typical of speculative biotech names than a photonics supplier. The stock now trades 23.8% below its 50-day moving average of €10.36, though it still holds 15% above the 200-day line of €6.87, reflecting the wide gap between near-term weakness and the longer-term growth narrative.
That narrative is entangled with litigation. A class action filed in late April alleges that POET misrepresented the likelihood of being classified as a Passive Foreign Investment Company for U.S. tax purposes, covering the period from April 1 to April 27, 2026. More damaging still, the suit claims a senior manager violated a confidentiality agreement during a public interview, prompting Celestial AI—a Marvell subsidiary—to cancel all outstanding orders with POET. The market reaction was brutal: on April 27, the stock cratered by an estimated 45% to 47% in a single session. The Marvell cancellation wiped out a key revenue stream and remains a central risk factor for shareholders.
Despite the legal turmoil, management is pressing ahead with its production timeline. The company confirmed at its June 26 annual meeting that the ramp-up of its 800G optical engine modules will begin in the second half of 2026 as planned. By the end of 2027, POET aims to reach a monthly capacity of one million units. Manufacturing partners Globetronics and Nationgates in Penang, Malaysia, have been aggressively hiring, a signal that many retail investors on platforms like Moomoo interpret as a precursor to mass production. The company also points to more than ten active customer projects that together represent over $100 million in potential annual revenue, and it plans to add roughly 50 employees globally.
Should investors sell immediately? Or is it worth buying POET Technologies?
On the commercial front, a bright spot emerged in June with a supply agreement from Lumilens: an initial order worth $50 million and a potential total of $500 million over five years. That deal helped offset some of the damage from the Marvell fallout, though it has yet to translate into meaningful revenue. POET’s first-quarter 2026 results underscore the challenge: revenue stood at just $503,389 against a net loss of $12.3 million.
To fund its ambitions, POET has raised approximately $830 million through equity offerings over the past twelve months, including a $400 million institutional placement in June that issued roughly 19 million shares at about $21 each. That price is far above the current trading level and has diluted existing holders significantly. An additional $661 million could be raised through outstanding warrants. The market capitalization now stands at €416.9 million.
Analysts remain broadly optimistic, with a consensus 12-month price target of $17.50—implying nearly 100% upside from the recent U.S. close. However, firms like Photon Capital caution that the company has yet to demonstrate that its order book can translate into actual revenue. Technical analysts at Stock Data Analytics flagged a bull-flag formation on July 15 with a 73% success probability and a risk-reward ratio of 2:1, though the pattern targets only $9.10—a modest gain from current levels. Support is pegged at $7.82, with resistance at $20.81.
POET Technologies at a turning point? This analysis reveals what investors need to know now.
For the weeks ahead, two factors will likely determine the direction of this high-stakes name: the outcome of the class-action proceedings and tangible progress on the production ramp-up in Malaysia. The presence of Citadel and Jane Street suggests that sophisticated capital sees value beneath the legal cloud, but the operational reality remains as volatile as the stock itself.
Ad
POET Technologies Stock: New Analysis - 15 July
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
